Scientists hunt for relapse clues in childhood leukemia gene
NCT ID NCT06649253
First seen Jan 09, 2026 · Last updated May 14, 2026 · Updated 17 times
Summary
This study aims to understand why about 20% of children with B-acute lymphoblastic leukemia (B-ALL) relapse after treatment. Researchers will analyze bone and blood samples from 50 newly diagnosed children at three critical points during therapy. They focus on a protein called CD9 and the genetic switches that control it, hoping to find markers that predict relapse.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LEUKEMIA, LYMPHOBLASTIC, ACUTE, PEDIATRIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU Angers
RECRUITINGAngers, France
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU Brest
RECRUITINGBrest, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
CHU Rennes
RECRUITINGRennes, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.